Properties (58)
Predicate | Object |
---|---|
gptkbp:instanceOf |
legal case
|
gptkbp:analyzes |
several months
several years fraudulent claims |
gptkbp:appeal |
possible
|
gptkbp:caseTypes |
5:18-cr-00258
|
gptkbp:chargingTime |
conspiracy to commit wire fraud
wire_fraud |
gptkbp:claims |
misleading investors
business decisions were legitimate endangering patients no fraud occurred |
gptkbp:community_engagement |
mixed opinions
healthcare_technology |
gptkbp:convictedOf |
pending
|
gptkbp:court |
gptkb:Ramesh_Balwani
gptkb:California not guilty unanimous complex financial fraud Judge_Edward_Davila |
gptkbp:date |
2022
|
gptkbp:decidedBy |
gptkb:United_States_District_Court
|
gptkbp:duration |
highly technical
|
gptkbp:education |
gptkb:University_of_California,_Berkeley
|
gptkbp:enforces |
gptkb:U.S._Attorney's_Office
|
gptkbp:finaleDate |
July 2022
|
gptkbp:homeGround |
Indian-American_entrepreneur
|
https://www.w3.org/2000/01/rdf-schema#label |
United States v. Balwani
|
gptkbp:impact |
startup culture
loss of millions misdiagnoses |
gptkbp:influenced |
Silicon_Valley_ethics
|
gptkbp:involves |
gptkb:Ramesh_Balwani
Theranos |
gptkbp:launchDate |
March 2022
|
gptkbp:led_to |
gptkb:FBI
|
gptkbp:legalStatus |
high-profile fraud case
|
gptkbp:media_coverage |
extensive
|
gptkbp:notableFeature |
regulatory scrutiny
investor confidence public trust in healthcare legal accountability in tech startup funding challenges |
gptkbp:outcome |
significant media attention
guilty verdict |
gptkbp:precedent |
corporate fraud cases
|
gptkbp:profession |
former software executive
|
gptkbp:regulatoryCompliance |
former_president_of_Theranos
|
gptkbp:related_to |
gptkb:Elizabeth_Holmes
investor lawsuits |
gptkbp:relatedPatent |
gptkb:United_States_v._Holmes
2018 |
gptkbp:research |
financial records
emails testimony from former employees |
gptkbp:research_focus |
Theranos_practices
|
gptkbp:tactics |
lack of intent
|